Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT00979134
Eligibility Criteria:
Inclusion Criteria:
* Minimum life expectancy of 12 weeks
* The presence of a solid, malignant tumour that is resistance to standard therapies or for which no standard therapies exist
* In the expansion for the study patients must have a tumour at least 1cm in size that can be measure using a CT or MRI scan, and provide a tumour sample to the sponsor company for testing of FGFR1 and/or 2 amplification
* Expansion, 5 groups of advanced cancer
* Solid tumours,FGFR1 and/or FGFR2 gene amplified
* Squamous NSCLC, FGFR1 gene low \& high amplified
* Gastric adenocarcinoma, including the lower oesophagus/gastro-oesophageal junction, FGFR2 gene low \& high amplified
* Aged at least 25 years
Exclusion Criteria:
* Treatment with any other chemotherapy, immunotherapy or anticancer agents within 3 weeks before the first dose of study
* An inability to be able to take the study medication
* A bad reaction to AZD4547 or any drugs similar to it in structure or class.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
149 Years
Study:
NCT00979134
Study Brief:
Protocol Section:
NCT00979134